Dr. Bhuvanesh Dave is the Founder and Chief Scientific Officer of Spanios, specializing in cancer biology. With over 17 years of experience, he has led drugs to phase 3 clinical trials and holds expertise in utilizing preclinical 3D cancer tumor organoid models to uncover mechanisms of action for novel therapeutics. His leadership includes adhering to Good Laboratory Practice (GLP) and Good Management Practice (GMP), ensuring safety protocols, and achieving accurate, regulatory-compliant clinical results.